Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, today unveiled its new brand identity, reflecting the ...

Shares in Canadian drug-maker Patheon Inc. soared more than 30 per cent Friday after a Swiss group topped an earlier takeover offer for the company. The company's stock jumped 80 cents to close at ...

Drug maker Patheon Inc. reported Friday a profit of $500,000 (U.S.), reversing a year-ago loss of $8-million as its restructuring and cost-cutting program continued. Toronto-based Patheon, which ...

The strange takeover battle for Canadian drug-maker Patheon Inc. took new twists on Thursday, as one suitor's offer for the company expired, even as it accused another suitor of launching its own ...

Patheon Inc. CEO Wes Wheeler stated, "Our new PDS facility will be of strategic importance in order to feed the pipeline of Patheon's two commercial sites located in Italy , offering clients a one ...

Removing the impact of income taxes, Patheon's third-quarter loss would have increased to $3.2-million from $1-million. Revenue for the contract drug maker rose to $172.7-million from $163.3-million.

TORONTO – Cinram International Income Fund (TSX:CRW.UN) has appointed John H. Bell, former CFO of contract pharmaceutical manufacturer Patheon Inc. (TSX:PTI), as its chief financial officer. Bel ...

DURHAM, NC-- (Marketwired - March 20, 2015) - Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has closed the ...

Drug manufacturer Patheon Inc. is moving its corporate head office from Mississauga to Research Triangle Park in North Carolina. The company said yesterday that “there will be no impact to ...

Patheon to restructure its operations in Burlington, Ont., in cost-saving move By David Paddon The Canadian Press Posted September 9, 2011 4:04 am 3 min read ...